Physician profile
Dan Dan
NPI 1326043472
$40,090.63
in general payments reported to CMS, 2019-2025
14 companies · $3,555 in 2025
The $3,555 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,719 · 2020: $16K · 2021: $7,795 · 2022: $1,119 · 2023: $2,628 · 2024: $1,623 · 2025: $3,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Food and Beverage: $3,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Food and Beverage | $3,306.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $13,935.55 | 2019-2020 | |
| Biosense Webster, INC. | $13,075.61 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro |
| Medtronic, INC. | $8,934.91 | 2021-2025 | Atakr II, Flexcath Advance, Na |
| Abbott Laboratories | $2,860.72 | 2019-2025 | Aveir, Jot Dx |
| Medical Device Business Services, INC. | $606.40 | 2019 | |
| Boston Scientific Corporation | $329.79 | 2019-2025 | Watchman Flx, Versacross Large Access Solution, Watchman Access System |
| Biotronik INC. | $137.16 | 2024 | Amvia Edge |
| Novartis Pharmaceuticals Corporation | $124.51 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $19.55 | 2021 | |
| Abiomed | $18.16 | 2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $17.66 | 2023 | Eliquis |
| Shockwave Medical, INC | $16.43 | 2022 | |
| Pfizer INC. | $14.18 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Dan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.